Health TrialsbyHealthPanel

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

ConditionH. Pylori Infection
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorSohag University

About this trial

This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: >18 years old.

H. pylori infection: Confirmed by histopathology or non-invasive tests (e.g., stool antigen test).

Disqualifiers

Prior H. pylori treatment: Previous treatment for H. pylori infection.

Allergies: Known allergies to study medications or components.

Patients cannot finish treatment course.

Patient missed follow up.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection

    Drug

    we assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient.

  • Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection

    Drug

    we assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

  • Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection

    Drug

    we assess the efficacy of PPI based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

Treatment groups

150 Participants
are divided into 3 treatment groups
Group A: Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infectionActive comparator 1 intervention
Group B: Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infectionActive comparator 1 intervention
Group C: Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infectionActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

efficacy medical treatment for eradication of Helicobacter Pylori infection in naive patient.

stool antigen for H. Pylori

Time frame
4 weeks after successful medical treatment

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov
Apply now